Histopathological characteristics of small diameter melanocytic naevi

Journal of Clinical Pathology

Volumn 56, Issue 6, 2003, Pages 459-464

  Braun Falco, M ^a   Hein, R ^a   Ring, J ^a   McNutt, N S ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOLOGY; DIAGNOSTIC PROCEDURE; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MICROSCOPY; PRIORITY JOURNAL;

EID: 0038648588     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.6.459     Document Type: Article

References (29)

1. Bataille V, Bishop JA, Sasieni P, et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Dermatol 1996;73:1605-11.
2. Garbe C, Büttner P, Wieß J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol 1996:102:695-9.
3. Grob JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990;66:387-95.
4. Schneider JS, Moore DH, Sagebiel RW. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi. Arch Dermatol 1994;103:202-5.
5. Snels DG, Hille ET, Gruis NA, et al. Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic. J Am Acad Dermatol 1999;40:686-93.
6. Skender-Kalnenas TM, English DR, Heenan PJ. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995;33:1000-7.
7. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-19.
8. Clark WH, Jr, Tucker MA. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma. Hum Pathol 1998;29:8-14.
9. Bergman R, Katz I, Lichtig C, et al. Malignant melanomas with histologic diameters less than 6 mm. J Am Acad Dermatol 1992;26:462-6.
10. Gonzalez A, West AJ, Pitha JV, et al. Small-diameter invasive melanomas: clinical and pathologic characteristics. J Cutan Pathol 1996;23:126-32.
11. Kamino H, Kiryu H, Ratech H. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis. J Am Acad Dermatol 1990;22:1032-8.
12. Koch SE, Henneberry JM. Clinically subtle primary cutaneous melanoma. J Am Acad Dermatol 1999;40:252-4.
13. Barnhill RL, Roush GC. Correlation of clinical and histopathologic features in clinical atypical melanocytic nevi. Cancer 1990;67:3157-64.
14. Barnhill RL, Roush GC, Duray PH. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol 1990;21:51-8.
15. Urso C. Atypical histologic features in melanocytic nevi. Am J Dermatopathol 2000;22:391-6.
16. Klein LJ, Barr RJ. Histologic atypia in clinically benign nevi. J Am Acad Dermatol 1990;22:275-82.
17. Annessi G, Cattaruzza MS, Abeni D, et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol 2001;45:77-85.
18. Clemente C, Cochran AJ, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organisation melanoma programme. Hum Pathol 1991;22:313-19.
19. Mooi WJ. The dysplastic naevus. J Clin Pathol 1997;50:711-13.
20. Murphy GF, Mihm MC. Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. Hum Pathol 1999;30:506-12.
21. Rhodes AR, Mihm MC, Weinstock MA. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol 1989;2:306-19.
22. Weinstock MA, Barnhill RL, Rhodes AR, et al. Reliability of the histopathologic diagnosis of melanocytic dysplasia. Arch Dermatol 1997;133:953-8.
23. Duncan LM, Berwick M, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993;100:318S-21S.
24. Duray PH, DerSimonian R, Barnhill R, et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol 1992;27:741-9.
25. Hastrup N, Clemmensen OJ, Spaun E, et al. Dysplastic naevus: histological criteria and their inter-observer reproducibility. Histopathology 1994;24:503-9.
26. Pozo L, Naase M, Cerio R, et al. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol 2001;115:194-204.
27. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997;277:1439-44.
28. Piepkorn M, Meyer JM, Goldgar D, et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989;20:407-15.
29. Grob JJ. The "ugly duckling" sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol 1998;134:103-4.